BHV-1100

N/A

Report date: 2024/04/24 11:57:37
NME

Base Information

Drug NameBHV-1100
Drug Alias NameCD38 ARM-Kleo Pharmaceuticals/PeptiDreamKP-1237BHV-1100
ClassificationSmall molecules
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsLymphocyte differentiation antigen CD38 inhibitors
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Pharmaceuticals IncKleo PharmaceuticalsPeptiDream Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncBiohaven Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A